Moreover, in an MC38 colon tumor mouse model, animals treated with dual anti-TIGIT/PD-1 antibodies exhibited heightened secretion of IFN-γ by CD4+ TILs in comparison to those treated solely with anti-PD-1 therapy (277). Here, TIGIT is linked to colonic neoplasm.